Loading...
Off-label studies on apremilast in dermatology: a review
PURPOSE: Apremilast is a phosphodiesterase-4 inhibitor FDA approved for psoriatic arthritis and moderate to severe plaque psoriasis. In recent years, multiple studies have suggested other potential uses for apremilast in dermatology. A summary of these various studies will be a valuable aid to derma...
Saved in:
| Published in: | J Dermatolog Treat |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6774908/ https://ncbi.nlm.nih.gov/pubmed/30935262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/09546634.2019.1589641 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|